Cannabis Clinical Trials

AXIM Biotechnologies received $4 million in institutional funding to advance clinical trials for cannabis chewing gum for the treatment of irritable bowel syndrome (IBS) and pain and spasticity in multiple sclerosis (MS). The secured funds will also allow the company to continue its bioequivalency study.   The bioequivalency study seeks to develop the prototype chewing […]

AXIM Biotechnologies received $4 million in institutional funding to advance clinical trials for cannabis chewing gum for the treatment of irritable bowel syndrome (IBS) and pain and spasticity in multiple sclerosis (MS). The secured funds will also allow the company to continue its bioequivalency study.   The bioequivalency study seeks to develop the prototype chewing […]

Medlab Clinical (ASX:MDC) has received approvals to begin human trials of two different cannabis based medicines – NanaBis and NanaBidial. NanaBis is packaged as a mouth spray and will be clinically tested in advanced stage cancer patients with intractable pain. The drug is expected to meet a global need for better pain management, with research […]

Members of the President Donald TrumpDonald TrumpDem tells Trump to remove family event planner as head of NY federal housing Can marijuana help mitigate America’s opioid crisis? The Hill’s 12:30 Report MORE‘s Commission on Combating Drug Addiction and the Opioid Crisis will hold their first meeting today. The Commission is tasked with studying “ways to […]

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). […]

In Congressional testimony on Tuesday, Deputy Attorney General Rod Rosenstein proved that he knows little about the science surrounding medical marijuana. In response to a question from Washington Rep. Derek Kilmer, Rosenstein repeated the canard that the plant lacks any accepted therapeutic utility. “Scientists have found no accepted medical use for it,” he opined. In […]

A marijuana-based drug has shown promising results as a treatment for a rare and deadly form of epilepsy in its first large-scale clinical trial. In the randomized trial of the cannabis derivative, cannabidiol, scientists showed a significant reduction in seizures among children suffering from Dravet syndrome—a complex disease that leads to developmental problems and has […]

Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of either whole-plant cannabis or specific cannabinoids, according to a literature review published in the journal Critical Reviews in Plant Sciences. A pair of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focuses […]

Medical cannabis has gained widespread acceptance throughout North America, but many physicians are still hesitant to prescribe the drug without evidence from clinical trials. While many companies are developing synthetic drugs based on cannabinoids, there are some companies that remain committed to realizing the synergistic capabilities of the whole cannabis plant and proving its therapeutic […]